Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

SELL
$161.01 - $317.85 $49,269 - $97,262
-306 Reduced 4.28%
6,848 $2.17 Million
Q3 2023

Nov 01, 2023

SELL
$164.66 - $218.08 $170,423 - $225,712
-1,035 Reduced 12.64%
7,154 $1.21 Million
Q2 2023

Aug 14, 2023

SELL
$176.32 - $240.22 $63,298 - $86,238
-359 Reduced 4.2%
8,189 $1.78 Million
Q1 2023

May 15, 2023

BUY
$161.33 - $204.36 $1.38 Million - $1.75 Million
8,548 New
8,548 $1.55 Million

Others Institutions Holding KRTX

About Karuna Therapeutics, Inc.


  • Ticker KRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,965,000
  • Description
  • Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...
More about KRTX
Track This Portfolio

Track Orion Portfolio Solutions, LLC Portfolio

Follow Orion Portfolio Solutions, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orion Portfolio Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orion Portfolio Solutions, LLC with notifications on news.